We are prescreening for the SND11 study on Schizophrenia in Adolescents. The purpose of the study is to evaluate the safety and effectiveness of an investigational drug called NaBen® for the treatment of Schizophrenia in Adolescents. Participation in this study would last about 10 weeks and would require up to 7 visits to a study site.
To see if your child meets the preliminary criteria for this study, we need to ask you some questions about your child’s health history and present condition. You do not have to answer any questions you do not want to answer. If your child qualifies for this study, you can find a study site close to you by “Finding a Trial Site.” You can also contact toll-free number 866-971-0917 to speak to one of the study staff about the study, eligibility to participate, site referrals, etc. We will refer you to a local study site if applicable for further study procedures if you choose to. You can choose to discontinue your cooperation with the site at any time, and can ask the site not to call you again if you decide to. Do you like to proceed to prescreening?